Other News To Note
Thallion Pharmaceuticals Inc., of Dorval, Quebec, said the effective net cash in the amended agreement for its acquisition by Bellus Health Inc., of Laval, Quebec, equals at least $7.5 million, including proceeds from the exercise or cancellation of "in-the-money" options of approximately $500,000, resulting in at least $0.1765 per common share in cash to Thallion's shareholders.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST